Do We “Do No Harm” in the Management of Acute Cholecystitis in COVID-19 Patients?
The diversity in responses by the surgical community and uncertainty regarding the management of acute cholecystitis highlights the challenges we face during this pandemic. Because COVID-19 can significantly complicate the perioperative course, the decision of whether or not to operate on these pati...
Gespeichert in:
Veröffentlicht in: | The American surgeon 2020-07, Vol.86 (7), p.748-750 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The diversity in responses by the surgical community and uncertainty regarding the management of acute cholecystitis highlights the challenges we face during this pandemic. Because COVID-19 can significantly complicate the perioperative course, the decision of whether or not to operate on these patients/carriers with acute cholecystitis has become complex. [...]it may be more reasonable to consider cholecystectomy for acute cholecystitis as we would prior to the COVID-19 crisis. [...]far, there is no high-quality data supporting the definitive role of cholecystostomy tube in the treatment of acute calculous cholecystitis. [...]the decision to pursue the treatment of acute cholecystitis in COVID-19 patients must be made with the principle of primum non nocere in mind. |
---|---|
ISSN: | 0003-1348 1555-9823 |
DOI: | 10.1177/0003134820939881 |